The legacy of Viagra, and its parent company copyright, presents a intriguing case study for investors. Initially a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of generic competition , significantly eroding its position . While certain pharmaceutical companies may seek to capitalize on related